The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,018.00
Bid: 12,018.00
Ask: 12,022.00
Change: -6.00 (-0.05%)
Spread: 4.00 (0.033%)
Open: 11,950.00
High: 12,142.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-London stocks slip after glum GDP data, end with second week of gains

Fri, 10th Dec 2021 10:09

* AstraZeneca falls on price target cut

* UK economy barely grew in October

* Data raises doubts around rate hikes

* FTSE 100 off 0.4%, FTSE 250 down 0.9%
(Adds comments, updates prices throughout)

By Bansari Mayur Kamdar

Dec 10 (Reuters) - UK's FTSE 100 and mid caps indexes
slipped for a third straight session on Friday after data
pointed to stalling economic growth in Britain, even before the
emergence of the Omicron coronavirus variant, but ended their
second week in the black.

The benchmark FTSE 100 index eased 0.4% pressured by
the healthcare sector after heavyweight drugmaker
AstraZeneca fell 2.0% after Berenberg cut its price
target on the stock.

The main index clocked its biggest weekly gain in eight
months, boosted by a strong recovery in mining stocks.

"We're seeing a flight to safety with defensive names like
British American Tobacco on the front foot," said Justin
McQueen, market analyst at DailyFX.

"The sort of news around Omicron and the government
announcing its plan B and suggestions around plan C does put the
final nail in the coffin for a rate rise next week."

Data showed Britain's economy grew by a weaker-than-expected
0.1% in October, leaving it 0.5% smaller than it was in February
2020, just before the country went into its first COVID-19
lockdown.

"The big drop in people visiting pubs, bars and restaurants
doesn't bode well for the idea that we're all rediscovering our
freedom post-lockdown. Perhaps this catalyst has now played out
and people are yearning for the warmth of their home during the
autumn and winter instead," said Russ Mould, investment director
at AJ Bell.

The domestically focussed mid-cap index fell 0.9%,
after Ashmore Group dropped 2.7% as Goldman Sachs
downgraded the asset manager to "neutral".

The numbers further raised doubts about a December rate hike
after Prime Minister Boris Johnson this week announced new
coronavirus guidelines ordering people to work from home, wear
masks in public places and use vaccine passes for bit public
events.

Capping losses on the main index, miners
gained 0.7% tracking copper prices, and defensive stocks such as
consumer staples, which tend to be less sensitive to the
economic climate, also rose.

British American Tobacco gained nearly 2.5% after a
Wall Street Journal report that said the U.S. Senate was
dropping a proposal to impose higher taxes on vaping, oral
nicotine and other NGPs.
(Reporting by Bansari Mayur Kamdar in Bengaluru
Editing by Subhranshu Sahu, Amy Caren Daniel and Frances Kerry)

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.